Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/033,639external-prioritypatent/US4381295A/en
Application filed by Ortho Pharma CorpfiledCriticalOrtho Pharma Corp
Publication of FI844705A0publicationCriticalpatent/FI844705A0/fi
Publication of FI844705LpublicationCriticalpatent/FI844705L/fi
Publication of FI75230BpublicationCriticalpatent/FI75230B/fi
Application grantedgrantedCritical
Publication of FI75230CpublicationCriticalpatent/FI75230C/fi
FI844705A1979-04-261984-11-29Diagnostiskt foerfarande, vid vilket anvaends en ny monoklonal antikropp specifik mot maenniskans hjaelpare-t-celler och i foerfarandet anvaendbar komposition.
FI75230C
(fi)
Diagnostiskt foerfarande, vid vilket anvaends en ny monoklonal antikropp specifik mot maenniskans hjaelpare-t-celler och i foerfarandet anvaendbar komposition.